Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage Cell Signaling Technology
PhosphoSitePlus
HomeAbout PhosphoSiteUsing PhosphoSiteCuration ProcessContact
NIH-logos NIGMS Logo NIAAA Logo NCI Logo NIH Logo
Protein Page:
PTGFRN (human)
p Phosphorylation
ac Acetylation
me Methylation
m1 Mono-methylation
m2 Di-methylation
m3 Tri-methylation
ub Ubiquitination
sm Sumoylation
ne Neddylation
gl O-GlcNAc
ga O-GalNAc
pa Palmitoylation
ad Adenylylation
sn S-Nitrosylation
ca Caspase cleavage
sc Succinylation

Overview
PTGFRN Inhibits the binding of prostaglandin F2-alpha (PGF2- alpha) to its specific FP receptor, by decreasing the receptor number rather than the affinity constant. Functional coupling with the prostaglandin F2-alpha receptor seems to occur. Note: This description may include information from UniProtKB.
Protein type: Cytoskeletal protein; Membrane protein, integral
Cellular Component: Golgi apparatus; endoplasmic reticulum membrane; integral to membrane
Molecular Function: protein binding
Reference #:  Q9P2B2 (UniProtKB)
Alt. Names/Synonyms: CD315; CD9 partner 1; CD9P-1; CD9P1; EWI-F; EWIF; FLJ11001; FPRP; Glu-Trp-Ile EWI motif-containing protein F; KIAA1436; Prostaglandin F2 receptor negative regulator; Prostaglandin F2-alpha receptor regulatory protein; Prostaglandin F2-alpha receptor-associated protein; PTGFRN; SMAP-6
Gene Symbols: PTGFRN
Molecular weight: 98,556 Da
Basal Isoelectric point: 6.16  Predict pI for various phosphorylation states
Select Structure to View Below

PTGFRN

Protein Structure Not Found.


STRING  |  neXtProt  |  Protein Atlas  |  BioGPS  |  Scansite  |  Pfam  |  Phospho.ELM  |  NetworKIN  |  UniProtKB  |  Entrez-Gene  |  GenPept  |  Ensembl Gene


Modification Sites and Domains Show Modification Legend
Click here to view phosphorylation modifications only

Modification Sites in Parent Protein, Orthologs, and Isoforms Show Modification Legend
 

Show Multiple Sequence Alignment


 SS 

SS: The number of records in which this modification site was determined using site-specific methods. SS methods include amino acid sequencing, site-directed mutagenesis, modification site-specific antibodies, specific MS strategies, etc.


 MS 

MS: The number of records in which this modification site was assigned using ONLY proteomic discovery-mode mass spectrometry.


       human

 
0 1 S150-ga DSLHVGPsARPPPSL
0 1 Y215-p GLGYEQRyHSGDVRL
0 1 T271 EKAVEVATVVIQPSV
0 1 N286 LRAAVPKNVSVAEGK
0 1 T495-p FIFSKEHtDtFNFRI
0 1 T497-p FSKEHtDtFNFRIQR
0 2 S531-p RNNSWVKsKDVFSKP
0 1 T566-p PFFAAGNtFEMTCKV
0 1 S574-p FEMTCKVssKNIKSP
0 1 S575-p EMTCKVssKNIKSPR
0 15 S875-p RERRRLMsMEMD___
  mouse

 
S150 DALVVGPSSRPPPGL
Y215 GPGYEQRYHSGDVRL
T271 EKAVEVATVVIQPTA
T286 LQLAVPRTVSVTEGK
T495 FIFSKEHTDTFNFRI
T497 FSKEHTDTFNFRIQR
S531 RNNSWVKSKDVFSKP
T566 PFFAAGNTFEMTCKV
S574 FEMTCKVSSKNIKSP
S575 EMTCKVSSKNIKSPR
S875-p RERRRLMsMEMD___
  rat

 
S150 DALVVGPSSRPPPGL
Y215 GPGYEQRYHSGDVRL
T271-p EKAVEVAtVVIQPTA
T286-p LQLAVPRtVSVTEGK
T495 FIFSKEHTDTFSFRI
T497 FSKEHTDTFSFRIQR
S531 RNSSWVKSKDVFSKP
T566 PFFAAGNTFEMTCKV
S574 FEMTCKVSSKNIKSP
S575 EMTCKVSSKNIKSPR
S875 RERRRLMSMEMD___
Home  |  Curator Login With enhanced literature mining using Linguamatics I2E I2E Logo Produced by 3rd Millennium  |  Design by Digizyme
©2003-2013 Cell Signaling Technology, Inc.